• Caspase-3 Colorimetric Assay Kit: Technical Protocol & QC Gu

  2026-07-01

  The Caspase-3 Colorimetric Assay Kit supports precise, DEVD-dependent caspase-3 activity measurement, enabling rapid apoptosis assays in neurodegenerative disease research and other cell death studies. This kit is optimized for workflows requiring quantitative detection of cysteine-dependent aspartate-directed protease activity, but should not be used to infer upstream pathway mechanisms or for non-caspase-3 targets.

• Technical Guide: Cathepsin B Inhibitor CA-074 for Research W

  2026-07-01

  Cathepsin B inhibitor CA-074 (SKU A1926) offers researchers a selective and potent means to block cathepsin B activity, facilitating studies of cancer metastasis, neurotoxicity, and immune response modulation. This compound is best suited for experiments requiring high specificity toward cathepsin B, but should not be used where broad-spectrum cysteine protease inhibition is needed or long-term solution stability is critical.

• Human Gastrin I Peptide: Driving Precision GI Organoid Resea

  2026-06-30

  Human Gastrin I peptide is redefining gastric acid secretion pathway research by enabling highly controlled, reproducible experiments in hiPSC-derived intestinal and gastric organoid systems. Explore protocol enhancements, advanced troubleshooting, and comparative insights that set APExBIO’s product apart as the gold standard for gastrointestinal physiology studies.

• Molecular Mechanisms of Paroxetine: Beyond SSRI Activity

  2026-06-30

  The reference review comprehensively delineates the molecular mechanisms of action of paroxetine, highlighting its high selectivity as a serotonin reuptake inhibitor and its additional inhibitory effects on cytochrome P450 enzymes and multiple kinases. These multifaceted interactions have implications for both neuropsychiatric and emerging non-psychiatric research applications.

• Tau Ser356 Phosphorylation and NUAK Inhibition in Alzheimer’

  2026-06-29

  Taylor et al. (2023) present evidence that tau phosphorylated at serine 356 (p-tau Ser356) accumulates in Alzheimer’s disease and is closely linked to neurofibrillary tangle pathology. Their work demonstrates that pharmacological inhibition of NUAK1 can selectively reduce this tau species in both mouse and human brain tissue, informing development of targeted therapeutics.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-06-29

  This study elucidates how p-cresyl sulfate, a uremic toxin elevated in chronic kidney disease, directly enhances calcification of aortic valvular interstitial cells by downregulating klotho and sirtuin-1 signaling. The findings highlight mechanistic intervention points for mitigating cardiovascular risk in uremic conditions and inform the design of endothelial dysfunction research.

• Steroid-Induced Protoplast Lysis: Mechanisms and Membrane In

  2026-06-28

  Smith and Shay's 1965 study innovatively used bacterial protoplasts to dissect the lytic action of synthetic steroids, illuminating the primacy of membrane interactions over cell wall barriers in antimicrobial susceptibility. Their findings, which detail how stabilizers and antagonists modulate steroid-induced lysis, provide foundational mechanistic guidance for contemporary polyene antifungal antibiotic research.

• Applied NMDA (N-Methyl-D-aspartic acid) for Retinal Models

  2026-06-27

  NMDA (N-Methyl-D-aspartic acid) is a gold-standard tool for modeling excitotoxicity and oxidative stress in neural tissues. This article delivers actionable workflows, troubleshooting tips, and insights into leveraging APExBIO's NMDA for robust neurodegenerative disease research, exemplified by advanced glaucoma models.

• Mildronate-Derived Lipidoids Enable Low-Inflammation mRNA De

  2026-06-26

  The reference ACS Nano study introduces mildronate-derived cationic lipidoids as novel lipid nanoparticle (LNP) components for mRNA vaccine delivery, achieving high transfection efficiency with markedly reduced inflammatory side effects in preclinical melanoma models. These findings highlight a promising strategy for safer and more effective mRNA vaccine platforms, with direct implications for immunogen design and translational research.

• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-06-26

  The referenced study illuminates how MLKL polymerization targets lysosomal membranes, inducing permeabilization and releasing cathepsin B to execute necroptosis. This mechanistic insight refines our understanding of regulated necrotic cell death and highlights new intervention points for disease models involving cell death and inflammation.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-06-25

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists (GRAs) targeting improved glycemic control for type 2 diabetes mellitus. The research highlights innovative synthetic strategies, with a focus on amide bond formation and structure-activity relationship optimization, offering new directions for metabolic disease drug design.

• Technical Guidance: Cathepsin B inhibitor CA-074 (SKU A1926)

  2026-06-25

  Cathepsin B inhibitor CA-074 enables selective, high-affinity blockade of cathepsin B protease activity in research models. It is suitable for dissecting cathepsin B–dependent mechanisms in cancer metastasis, neurotoxicity, and immune modulation, but should not be used in studies requiring pan-cathepsin inhibition or in protocols with extended solution storage. Application is best suited to workflows where high selectivity and short-term solution use are critical.

• Torin2 and the Future of mTOR Inhibition in Translational On

  2026-06-24

  This article provides a mechanistic and strategic roadmap for translational researchers leveraging Torin2, a next-generation mTOR inhibitor, to dissect regulated cell death in cancer models. Integrating the latest mechanistic insight from RNA Pol II-driven apoptotic signaling, we outline protocol parameters, competitive positioning, and actionable guidance for robust experimental design. The discussion synthesizes recent high-impact findings and positions Torin2 as a uniquely potent and selective tool, highlighting its value in advanced apoptosis assays and translational cancer research workflows.

• Tunicamycin as a Strategic N-Glycosylation Inhibitor in Canc

  2026-06-23

  Explore how Tunicamycin, a potent N-glycosylation inhibitor, underpins advanced cancer and inflammation research by dissecting glycosylation-dependent mechanisms. This article uniquely connects ER stress modulation to therapeutic innovation, offering actionable guidance for assay design.

• RAB31 Regulates an ESCRT-Independent Exosome Pathway

  2026-06-23

  The reference study identifies RAB31 as a dual-function regulator of exosome biogenesis, operating via an ESCRT-independent mechanism. This discovery clarifies how specific membrane proteins, including EGFR, are sorted and secreted in exosomes, advancing our understanding of intercellular communication and protein trafficking.

11387 records 1/760 page Next 12345 下5页 Last page